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Peptide Functionalized Surfactant MSNs
Sonia Barrett, Lauren Chlebanowski, Stefan H. Bossmann
Department of Chemistry, College of Arts and Science
Abstract
Antibiotic resistance in bacteria has become a rising problem 
since the first antibiotic was created, further aggravated by the 
improper overuse to treat common infections. Because of this 
pharmaceutical companies must keep making new and stronger 
antibiotics. Surfactants are plentiful and effective killers of many 
surface bacteria and are also varied in their structure. All have a 
hydrophilic head and long hydrophobic carbon chain. These long 
hydrophobic carbon chains can pierce through the lipid bilayers 
that make up bacteria cell membranes and cause cytoplasmic 
leakage and lysis of the cell wall, leading to cell death. One 
proposed surfactant is synthesized by taking N-benzylamino
ethanol dissolved in absolute ethanol and adding 1-
bromododecane in excess then left to reflux. Mesoporous silica 
nanoparticles, or MSNs, are versatile drug delivery vessels that 
can uptake a variety of drugs in simple one pot synthesis. The 
desired drug is dissolved in a typically basic solvent at critical 
micelle concentration, then Tetraethyl orthosilicate (TEOS) is 
added and the reaction is allowed to reflux until a precipitate is 
formed. The MSN can then be further functionalized with a 
gatekeeper to help target bacteria and force the loaded drug inside 
the MSN to be released when desired. In this case a peptide chain 
with Vancomycin attached to the end will be used to 
functionalize the MSNs. Both the synthesized surfactants and the 
loaded MSNs are tested against the model pathogen Micrococcus
luteus to test for their effectiveness in killing bacteria. In future 
work MSNs loaded with various surfactants will be synthesized 
and possible use of different bulky gatekeepers to functionalize 
the outside of MSNs will be considered.
Peptide Synthesis
Using solid phase synthesis the following peptide was made: 
Vancomycin-GSGLAG-LVGPAG-LAGAGSG 
Vancomycin was attached just like any other amino acid or florescent dye 
to the N-terminus end.
➢ It was mixed with HBTU in a 1:2.9 ratio by molecular weight. 
➢ Dissolved in a solvent mixture of DIEA and DMF in a1:29 ratio by 
volume.
➢ Left to spin with Peptide chain for a full 24 hours.
The completed peptide chain then has its protective resin group cleaved 




➢ Surfactant SB12 is a deadly antibiotic that kills by 
disrupting the cellular membrane lipid bilayer causing 
cytoplasmic leakage.
➢ The MSNs made in our lab are made using a simple 
one pot synthesis.
➢ The drug loaded into the MSN can be almost anything 
theoretically.
➢ The MSN is functionalized with a peptide chain 
connected to a large, bulky antibiotic.
➢ Peptide chain acts as a targeting system. Cleaving 
itself around certain enzymes found around 
infection sites and releasing the gatekeeper and 
therefore releasing the surfactant loaded into the 
MSN.
➢ Vancomycin acts as a gatekeeper, sterically 
blocking SB12 from being released, to control drug 




➢ Characterization of  SB12 loaded MSN using DLS and 
TGA
➢ Cell studies with model pathogen Micrococcus luteus
➢ Studies with unaltered peptide functionalized surfactant 
MSN to show that gatekeeper works and isn’t allowing 
SB12 to be released
➢ Studies with enzymes to show that peptide will cleave 
properly to allow the release of SB12
➢ Functionalize MSN with different peptide sequences
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➢ Surfactant SB12 at critical micelle concentration and 350µL 2M NaOH dissolved in water.
➢ 700µL TEOS and +100mg APTES mixed and added to solution slowly dropwise to avoid aggregation.
➢ Stirred and refluxed at 85ºC overnight.






The surfactant MSN is treated like an amino acid in solid phase peptide synthesis, attaching one of the various amine 
groups of the MSN to the C-terminus tail of the peptide chain.
➢ The surfactant MSN is mixed with HBTU in a 1:2.9 ratio by molecular weight.
➢ This mixture is dissolved in a solution of DIEA and DMF in a 1:29 ratio by volume.
➢ The dissolved MSN and HBTU is then swirled with the peptide for 24 hours.
The end product theoretically results in a MSN with a peptide chains attached to each amine groups on the surface of 
the MSN.
1-Bromododecane, 1,12-Dibromododecane, and N-
Benzylethanolamine in 2:1:2 ratio  dissolved in absolute 
ethanol and left to reflux at 90º C for 48 hours
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